Key result
This review discusses the conflicting long-term efficacy data between PCI and CABG for multivessel coronary artery disease, emphasizing the need for individualized patient care.
Why the study?
Does percutaneous coronary intervention compared to coronary artery bypass surgery improve long-term efficacy in patients with multivessel coronary artery disease?
Does percutaneous coronary intervention compared to coronary artery bypass surgery improve long-term efficacy in patients with multivessel coronary artery disease?
This review highlights the need for tailored revascularization strategies in multivessel disease based on patient-specific factors like diabetes and LV dysfunction.
Answers are grounded in this paper and cite their sources.
Supports individualized PCI/CABG decisions in multivessel disease amid conflicting data; leaves open optimal long-term strategy for prospective trials.
Coronary artery bypass surgery (CABG) and percutaneous coronary intervention (PCI) are both safe and established treatment modalities of invasive revascularization for patients with coronary artery disease (CAD). However, conflicting information exists when comparing the long-term efficacy of the two methods. The optimal treatment for patients with multivessel coronary artery disease (MVD) is still subject to discussion, given the lack of fairly designed, prospective, randomized data reflecting current practice in the modern era. Furthermore, the clinical outcomes after invasive revascularization differ according to the number of diseased vessels, presence or absence of diabetes, left main disease and left ventricular dysfunction. Hence, the question arises whether we should continue to use the term 'multivessel disease'. Conflicts of available data need to be addressed and overcome so that care of patients with CAD can be successfully tailored. In this review article we try to address some of the above conflicts, in an effort to improve our understanding in the care of patients with multivessel disease. We also provide an evidence-based perspective which may differ from the current standard of practice.
No takes yet. Share an insight, caveat, or question.
Soran et al. (2009) conducted a review in Multivessel coronary artery disease. Percutaneous coronary intervention (PCI) vs. Coronary artery bypass surgery (CABG) was evaluated. This review discusses the conflicting long-term efficacy data between PCI and CABG for multivessel coronary artery disease, emphasizing the need for individualized patient care.
Synapse has enriched 10 related papers. Consider them for comparative context: